EastWest Bioscience Stock Forecast for 2023 - 2025 - 2030
Updated on 05/19/2024
EastWest Bioscience Stock Forecast and Price Target
The average price target for EastWest Bioscience's stock lately set by several renowned analysts is 0.03, which would result in a potential downside of approximately 0% if it reaches this mark by December 31, 2024. This estimation is based on a high estimate of 0.04 and a low estimate of 0.03. Even if you are not interested in EAST stock, it is still imperative to be aware of its competitors.
0.00% Upside
EastWest Bioscience Fair Value Forecast for 2023 - 2025 - 2030
EastWest Bioscience's Price has grown in the last year, jumping from 0.00 to 0.00 – an increase of 100.00%. In the next year, analysts predict that Fair Value will reach 0.03 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| WEED Stock Forecast | Canopy Growth | Hold |
7
|
C$14.81 | Buy/Sell | C$0.94 | -59.49% |
| INNO Stock Forecast | InnoCan Pharma | - |
6
|
C$0.29 | Buy/Sell | C$0.00 | -100.00% |
| NGW Stock Forecast | Next Green Wave Holdings | - |
0
|
C$0.39 | Buy/Sell | C$0.00 | -100.00% |
| ACST Stock Forecast | Acasti Pharma | Buy |
0
|
$2.69 | Buy/Sell | $16.34 | 199.63% |
| CZO Stock Forecast | Ceapro | - |
0
|
C$0.27 | Buy/Sell | C$1.70 | -100.00% |
EastWest Bioscience Revenue Forecast for 2023 - 2025 - 2030
EastWest Bioscience's Revenue has grown in the last year, jumping from 920.00k to 1.03M – an increase of 11.96%. In the next year, 0 analysts estimate that EastWest Bioscience's Revenue will decrease by 10.68%, reaching 920.00k. According to professional forecasts, in 2030, EastWest Bioscience's Revenue will decrease by 6.55%, reaching 962.52k.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| FLOO.F Stock Forecast | Flower One Holdings | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% |
| CNFA Stock Forecast | CanaFarma Hemp Products | - |
0
|
C$0.05 | Buy/Sell | C$0.00 | -100.00% |
| XTRX Stock Forecast | Adastra Holdings | - |
0
|
C$0.21 | Buy/Sell | C$0.00 | -100.00% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CANQ.F Stock Forecast | CanaQuest Medical | - |
0
|
$0.10 | Buy/Sell | $0.98 | -100.00% |
| NLV Stock Forecast | New Leaf Ventures Inc | - |
0
|
C$0.04 | Buy/Sell | C$0.00 | -100.00% |
| GAIA Stock Forecast | Gaia Grow | - |
0
|
C$0.02 | Buy/Sell | C$0.00 | -100.00% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| VIBE Stock Forecast | Vibe Growth | - |
0
|
C$0.03 | Buy/Sell | C$0.54 | -100.00% |
| MOJO Stock Forecast | Mojave Brands | - |
4
|
C$0.26 | Buy/Sell | C$0.00 | -100.00% |
| IPOT Stock Forecast | Isracann Biosciences | - |
3
|
C$0.02 | Buy/Sell | C$0.00 | -100.00% |
EastWest Bioscience EBITDA Forecast for 2023 - 2025 - 2030
EastWest Bioscience's EBITDA has increased by 28.91% In the last year, going from -1.28M to -1.65M. 0 analysts predict EastWest Bioscience's EBITDA will decrease by 22.42% in the next year, reaching -1.28M. By 2030, professionals predict that EastWest Bioscience's EBITDA will decrease by 12.50%, to -1.44M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CFT Stock Forecast | Craftport Cannabis | - |
0
|
C$0.05 | Buy/Sell | C$0.00 | -100.00% |
| FUEL Stock Forecast | PlantFuel Life | - |
-16
|
C$0.01 | Buy/Sell | C$0.00 | -100.00% |
| J Stock Forecast | Lotus Ventures | - |
10
|
C$0.01 | Buy/Sell | C$0.00 | -100.00% |
EastWest Bioscience EBIT Forecast for 2023 - 2025 - 2030
In the last year, EastWest Bioscience's EBIT has grown, increasing from -1.40M to -1.77M – a growth of 26.43%. For the following year, the 0 analysts predict that EastWest Bioscience's EBIT will drop by 20.90%, reaching -1.40M. In 2030, the professionals' prediction is that EAST's EBIT will decrease by 11.81%, reaching -1.56M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CRFT Stock Forecast | BC Craft Supply | - |
0
|
C$0.50 | Buy/Sell | C$0.00 | -100.00% |
| CANA Stock Forecast | CannAmerica Brands | - |
0
|
C$0.02 | Buy/Sell | C$0.00 | -100.00% |
| WLNS.F Stock Forecast | Discover Wellness Solutions | - |
-19
|
$0.04 | Buy/Sell | $0.00 | -100.00% |
EastWest Bioscience EPS Price Prediction Forecast for 2023 - 2025 - 2030
EastWest Bioscience's EPS has grown in the last year, jumping from 0.00 to 0.00 – an increase of 100.00%. In the next year, analysts predict that EPS will reach 0.00 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| NHP Stock Forecast | Lumiera Health | - |
4
|
C$0.01 | Buy/Sell | C$0.00 | -100.00% |
| SE Stock Forecast | Sweet Earth Holdings | - |
-18
|
C$0.04 | Buy/Sell | C$0.00 | -100.00% |
| CBD.U Stock Forecast | Hempfusion Wellness | - |
0
|
$0.00 | Buy/Sell | $0.39 | 0.00% |
.jpg)